Chemokines in cancer related inflammation (Q37816561)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 04 December 2010

Language	Label	Description	Also known as
English	Chemokines in cancer related inflammation	scientific article published on 04 December 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

Chemokines in cancer related inflammation (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

Alberto Mantovani

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Federica Marchesi

3

0 references

author name string

Paola Allavena

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Giovanni Germano

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

0 references

publication date

4 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

317

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

664-673

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Inflammatory chemokines in cancer growth and progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Chemokines and chemokine receptors: new insights into cancer-related inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The chemokine system in cancer biology and therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Nuclear factor-kappaB in cancer development and progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Immune cells as mediators of solid tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Regulation of the macrophage content of neoplasms by chemoattractants

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Identification of GRO1 as a critical determinant for mutant p53 gain of function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Regulation of the chemokine receptor CXCR4 by hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Nf-kappa B, chemokine gene transcription and tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

NF-κB inducing kinase: A key regulator in the immune system and in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

A role for chemokine receptor transactivation in growth factor signaling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The chemokine system: redundancy for robust outputs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CCL2 (monocyte chemoattractant protein-1) and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Cancer and the chemokine network

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The inflammatory chemokines CCL2 and CCL5 in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Tumour-educated macrophages promote tumour progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Tumor immune escape by the loss of homeostatic chemokine expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Altered macrophage differentiation and immune dysfunction in tumor development

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Manipulating the chemokine-chemokine receptor network to treat cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Priming of naive T cells inside tumors leads to eradication of established tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Regulated expression of CCL21 in the prostate tumor microenvironment inhibits tumor growth and metastasis in an orthotopic model of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Cancer CXC chemokine networks and tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Expression of IP-10 related to angiogenesis in uterine cervical cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Oncogene-induced cell senescence--halting on the road to cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Living on a break: cellular senescence as a DNA-damage response

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Chemokine signaling via the CXCR2 receptor reinforces senescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Involvement of chemokine receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CXCR4 mediates the proliferation of glioblastoma progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CXCR4 is a major chemokine receptor on glioma cells and mediates their survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Functional CCR9 expression is associated with small intestinal metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Involvement of CXCL12 and CXCR4 in Lymph Node Metastases and Development of Oral Squamous Cell Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Tumour necrosis factor and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Identifiers

10.1016/J.YEXCR.2010.11.013

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37816561&oldid=1729067248"